BRAINSTORM CELL THERAPEUTICS INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
BRAINSTORM CELL THERAPEUTICS INC. has filed 949 SEC EDGAR filings since 24 May 2001

SEC filing history

Showing 151-175 of 725 matching filings.

Per page
25
Current page
7
424B5 File 333-258640

424B5

Filing date
19 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Jun 2023
Reporting date
19 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
21 Jun 2023
Reporting date
19 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
01 May 2023
Reporting date
01 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
01 May 2023
Reporting date
01 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
24 Apr 2023
Reporting date
20 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
24 Apr 2023
Reporting date
20 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79890

SC 13G/A

Filing date
05 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Jan 2023
Reporting date
07 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Jan 2023
Reporting date
18 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36641

DEF 14A

Filing date
13 Dec 2022
Reporting date
10 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .